Bausch Health Companies Financial Ratios
NYSE: BHCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
6.040.00 (0.00%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Bausch Health Companies ratio analysis
Bausch Health Companies earned a net margin of 1.5% in FY 2025, up from -0.5% a year earlier. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Bausch Health Companies financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 17.17 | — | — | — | — | — | — | — | 3.04 | — |
| Price / sales | 0.26 | 0.30 | 0.33 | 0.28 | 1.17 | 0.92 | 1.20 | 0.89 | 0.83 | 0.52 |
| Price / book | — | — | — | — | — | 13.80 | 9.74 | 2.73 | 1.24 | 1.60 |
| Gross margin | — | — | — | — | — | — | — | — | 71.3% | 73.4% |
| Operating margin | 17.7% | 16.1% | 11.0% | 5.6% | 5.3% | 8.4% | -2.4% | -28.4% | 1.2% | -5.9% |
| Net margin | 1.5% | -0.5% | -6.8% | -2.8% | -11.2% | -7.0% | -20.8% | -49.5% | 27.6% | -24.9% |
| Free cash flow margin | 9.8% | 13.1% | 9.3% | -11.6% | 13.7% | 10.1% | 14.3% | 16.0% | 24.3% | 19.1% |
| Return on equity (ROE) | — | — | — | — | — | -104.7% | -168.2% | -151.6% | 41.1% | -76.4% |
| Return on assets (ROA) | 0.6% | -0.2% | -2.2% | -0.9% | -3.2% | -1.8% | -5.3% | -12.8% | 6.4% | -5.5% |
| Debt / equity | — | — | — | — | — | 44.72 | 24.36 | 8.89 | 4.35 | 9.47 |
| Current ratio | 1.47 | 0.86 | 1.30 | 1.08 | 1.08 | 1.09 | 1.12 | 1.10 | 1.11 | 1.41 |
| Revenue growth | 6.7% | 9.9% | 7.8% | -3.7% | 5.1% | -6.7% | 2.6% | -3.9% | -9.8% | -7.4% |
| EPS growth | — | — | — | — | — | — | — | -272.9% | — | — |